Skip to main content

Table 6 Adjusted annual medical costsa per patient by types of renal replacement therapies (CNY, 95%CI)

From: Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China

 

Overall HD

Overall PD

KT (first year)

KT (second year)

No. Patients

3765

1237

117

41

Total annual medical costs (CNY)

94,760.5(85,166.6–106,972.2)

80,762.9(76,249.8–85,498.9)

132,253.0(114,009.9–153,858.6)

93,155.3(61,120.6–101,989.1)

 Laboratory and diagnostic costs (CNY)

724.7(257.2–1500.2)

309.1(195.7–481.8)

2325.4(2017.4–3260.2)

/

 Non-medication treatment costs (CNY)

73,801.2(69,423.2–79,717.3)

10,390.0(8323.3–13,617.0)

36,404.8(33,090.6–48,643.0)

6013.0(5194.4–7458.4)

 Medication costs (CNY)

19,527.1(14,657.2–26,696.9)

69,654.7(63,253.9–76,369.8)

89,598.9(69,504.8–106,162.1)

86,958.0(53,530.9–95,595.2)

 Bed fees (CNY)

350.1(133.9–743.3)

266.4(177.1–407.8)

2226.3(1648.0–4363.7)

/

 Other fees (CNY)

356.3(157.6–668.3)

151.0(85.8–252.1)

1698.6(1575.1–2179.4)

3.1(0.6–9.2)

Out-of-pocket spending (CNY)

12,302.0(9820.6–15,682.1)

11,508.3(7759.0–14,559.9)

31,281.3(24,042.6–36,188.1)

15,670.5(10,387.4–19,025.4)

  1. HD Haemodialysis, PD Peritoneal Dialysis, KT Kidney Transplantation
  2. aAdjusted for age, gender, insurance types and three comorbidities (hypertension, diabetes, coronary) status using the generalized linear models;
  3. CNY, Chinese Yuan; CI, Confidence Interval